Leukemias and Myeloid Disorders 1 Flashcards

(47 cards)

1
Q

Leukemia defined

A

Neoplastic proliferation of hematopoeitic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lymphomas and leukemias

A

Can be caused by the same cell types

Lymphomas are solid neoplasms of lymphoid cells outside the marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Leukemia leading cause of cancer death

A

In children/young adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which are most common

A

Acute and chronic each half

AML most common acute, CLL most common chronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sex and luekemia

A

Male mostly

Especially Hairy cell leukemia and T cell ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Inherited genetic and chromosomal risk for leukemia

A

Down sydnrome

Fanconis anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Radiation and drugs and leukemia

A

Radiation - increased risk of all except CLL

Drugs - alkylating agents, topoisomerase inhibitors increase risk of acute

Smoking increase AML risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Viral and leukemia

A

Human T cell leukemia virus and T cell leukemias/lymphomas

EBV or HHV-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Immune and leukemia

A

Chronic immune stimulation and immunodeficiency associated with increased risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mutations (common)

A

t(9;22) - Philly - Most CML and some ALL

t(15;17) - in promyelotic AML (retinoic acid receptor fuses with PML…tx with trans-retinoic acid)

t(8;21) in AML with maturation (favorable)

in(16) in AML with myelomonocytic diff and abnormal eosinophils (favorable)

t(12;21) in favorable ALL

11q23 (MLL gene) infantile ALL t(4;11), some AML following topoisomerase inhibitors (bad prognosis)

Trisomy 8, momnosomey, of chromosomes 5 and 7 associated with AML and myelodisplastic disroders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acute vs chonirc leukemia

A

Acute - fatal…at least 20% blast cells…sudden onset…marked cytopenias and more symtpoms

Chronic - greater cell maturation…better survival…more prominent splenomegaly…more gradual symptoms and mild cytopenias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical manifestations

A

Bone marrow - neutropenia, thrombocytopenia, anemia

Organ infiltration

INcreased metab and cell lysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bone
Lymphadenopathy
Splenomegaly

Types of leukemias

A

Bone pain, espeically in acute

LAD - in lymphoctyic anemias, mostly CLL

Spleno - Mild to mod in acute, mod in CLL, most in CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hepato
CNS
Skin
Myeloid sarcomas and leuk

A

Hepato - most in CLL
CNS - espeically ALLs, some AMLs
Skin - T cell and monocytic leukemias
Mye Sarc- bone or soft tissue infiltrates in AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cytochemistry used for

A

AML for most part

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cytogenics used for

A

CML confirmatory…subtypes of acute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ALL types

A

Precursor B or T lymphoblastic leukemia

Same cell may cause lymphoma but if 25% or more lymphoblasts in marrow then leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Most common patients with ALL

A

Children, adolescents (most common in childreN)

More in men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ALL subtype and flow cytometry…also symptoms

A

Bone pain, CNS< tests
May have low white count

Precurosr T (15%) - Mediastinal mass or lymphoma common )…more common in males

20
Q

Prognosis, morphology of ALL

A

95% of childrne into remission

Round and convoluted nuclei, small to medium with little cytoplasm, high grwoth rate

21
Q

AML primary population

A

Most adults and more male

22
Q

AML classifcation

A
Need cytogenics 
Recurring cytogenic abn (8;21), t(15;17)
Mylodysplasia related changes
Therapy related
NOS
23
Q

AML onset

A
Gum hyperplasia (esp in monocytic)
DIC in promyelocytic, may be aleukemic
24
Q

Morphology and flow cytometry and prognosis of AML

A

Auer rods…positive nezym estains

60% remission but most relapse

25
Favorable and unfavorable AML
Favorable - t(8;21), promyelocytic t(15;17), inv(16), isolated NPM 1 mutation Unfavorable - AML with myelodysplasia changes (del 5,7), therapy related AML, FLT3 mutations
26
Acute promyelocytic leukemia
t(15;17) Abnormal RAR...can lead to DIC Look for multiple auer rods and intense granularity ATRA is the therpay
27
Acute leukemia of ambiguous lineage
Primitive acute leukemias showing either insufficienct evidence of lymphoid or myeloid differentiation OR showing both myeloid and lymphoid or bothB and T cell differentiation Typically a poor prognosis
28
B lymphoid-myeloid cases mutations
t(9;22) or 11q23 (MLL)
29
CML mutation and ages
t(9;22) - Philly...c-abl transferred to bcr region of 22...increased tyrosine kinase activity...more cell division...doesn't block differentiation 26-60
30
Symptoms of CML and what to look for
Splenomegaly Netutrophilia with less than 5% blasts and all stages of myeloid precursors...basophilia 100% cellular bone marrow with increased small MK but full granulocytic maturation Thrombocytosis in 50%
31
CML blast phase
After about 3 years. Myeloid - 70% Lymphoid - 30%
32
Effect of MLL mutation, BCR-ABL mutation and RAR mutation
MLL - increased self renewal BCR-ABL - increased growth and survival RAR - differentiation blocked
33
Philly chromosome mutation and what it causes
CML and ALL | BCR-ABL fusion protein from t(9;22) is tyr kinase that activates pro-growht and survival
34
t(15;17) mutation
AML (promyelocytci) | PML-RARE fusion creates abnormal RAR
35
Core binding factor mutations
Disrupt TF needed (usually good prognosis) t(8;21) - AML with maturation inv (16) - monocytic AML with abnormal eosino t(12;21) - favorable ALL`
36
MLL mutation
11q23 Poor Histone modifying protein that allows prolif pathways to be turned on
37
Mature B cell and plasma cell markers
Kappa and lambda light chains
38
First tier of AML diagnosis
Cytogenics
39
In a nutshell
Is it acute leukemia (more than 20% blasts)...if yes then myeloid or lymphoid (flow)...if lymphoid, B or T (flow)...if myeloid, does it have recurring CG abnormality)..if not, then is there associated dysplasia or histroy of chemo or XRT...if not, is there maturation
40
Things for good diagnosis of precurosr B cell ALL
Hyperdiploidy t(12;21) mutation Age 2-10 with lower WBCs at diagnosis
41
Poor prognosis of B cell ALL
``` Hypodiploidy Under 1 or over 10 Higher WBC t(9;22) - BCR/ABL, Philly t(4;11) - AF4/MLL ```
42
AML with maturation
t(8;21) good prognosis Core binding factor mutations
43
Myelomonocytic AML
Inv (16) or t(16,16) | Abnormal eosinophils
44
Monocytic AML
11q23 MLL abn | Poor prognosis
45
Promyelocytic AML
t)15;17) Distinctive granules with Auer rods and DIC Good prognosis if treated
46
NPM1, FLT-3 and CEBPA
In AML with normal CG, prognositc significance ``` FLT-3 duplication - bad NPM 1 - good CEBPA - good FLT3 plus NPM1 - IM FLT3 plus CEPBA - ? ```
47
Alkylating agent and toposiomerase related changes
Alkylating - chr 5,7 loss Topo - 11q23